Lina Irawan
Taiwan has officially transitioned into a "super-aged society," a demographic milestone where more than 20% of the total population is aged 65 or older. This shift has placed unprecedented pressure on the nation’s healthcare infrastructure, primarily through the rising prevalence of chronic diseases, age-related disabilities, infectious threats, and various forms of cancer. While the Taiwan government has made significant strides in expanding healthcare access and increasing treatment capacity over the past decades, experts and policy committees now warn that the current framework remains overly focused on "downstream" care—treating illnesses after they become severe. To ensure the long-term sustainability of the National Health Insurance (NHI) system and the well-being of its citizens, the Lai Ching-te administration is being urged to pivot toward an "upstream" model centered on prevention, early intervention, and digital innovation.
The Demographic Imperative and the Healthy Taiwan Vision
The urgency for reform stems from a stark reality: as the population ages, the window to intervene in health outcomes narrows. Current data indicates that the average Taiwanese citizen spends approximately eight years of their life in "unhealthy" conditions, marked by disability or chronic illness before death. The administration’s "Healthy Taiwan" vision aims to shorten this period by fostering a resilient healthcare system capable of proactive risk management.
Central to this vision is the "888 Plan," a strategic initiative designed to tackle chronic diseases. However, the Committee for healthcare reform suggests that for these goals to be met, Taiwan must bridge the gap between fragmented existing programs. Current policies often lack alignment, leading to missed opportunities in early-stage intervention for aging-related conditions and the underutilization of sophisticated data-driven tools. A more integrated, outcome-oriented approach is required—one that connects chronic disease governance, healthy aging, immunization, and cancer control through robust public-private collaborations.
Precision Care: Redefining Chronic Disease Governance
Chronic diseases, particularly diabetes and chronic kidney disease (CKD), are the primary drivers of healthcare utilization in Taiwan. According to data from the National Health Insurance Administration (NHIA), these two conditions alone account for over NT$100 billion in annual expenditures. As the elderly population grows, these costs are projected to escalate, threatening the solvency of the NHI fund.
To mitigate this, the Committee recommends a transition to a "precision care" model. This approach moves away from a one-size-fits-all treatment plan and instead utilizes risk stratification to identify high-risk individuals before their conditions deteriorate. For example, patients with poor glycemic control or early signs of renal impairment would be prioritized for intensive, personalized management.
Furthermore, there is a recognized need to align financial incentives with health outcomes. Under current "Pay-for-Performance" (P4P) models, reimbursement points for early-stage CKD are significantly lower than those for metabolic syndrome or advanced diabetes. This disparity often discourages medical institutions from enrolling patients in early intervention programs. By establishing a National Chronic Disease Cross-Sector Alliance, the government could coordinate medical centers and primary care providers to ensure that clinical protocols are standardized and that data is shared seamlessly across the care continuum.
Addressing the Obesity Epidemic as an Upstream Strategy
In a notable shift, the Executive Yuan recently announced that "Healthy Taiwan" will prioritize obesity and fatty liver care. Obesity is increasingly recognized as a critical "upstream" driver of more severe chronic conditions. Drawing inspiration from international models, such as South Korea’s NHI, the Committee suggests integrating Body Mass Index (BMI) monitoring into the standardized 888 Program. By prioritizing overweight populations for longitudinal management—including lifestyle counseling and pharmacological interventions—Taiwan can prevent the progression to diabetes and cardiovascular disease, thereby enhancing system resilience.
Shifting Focus to Early Intervention in Age-Related Disability
One of the most significant challenges of a super-aged society is the rising burden of functional decline and dementia. Data from the Health Promotion Administration (HPA) reveals that roughly 30% of Taiwanese citizens aged 65 and above are at risk of frailty or disability. If left unaddressed, this will overwhelm the nation’s long-term care capacity.
The Committee advocates for a policy shift toward "brain health management." Currently, dementia policies are largely focused on moderate to severe cases. However, with the emergence of new biomarker-based diagnostics—such as blood-based screenings and PET scans—and disease-modifying therapies for Alzheimer’s, there is a golden opportunity to intervene at the "very mild" stage. By expanding access to these precision diagnostics, the healthcare system can slow cognitive decline and reduce the long-term caregiving burden on families.
Similarly, for stroke and neurodegenerative disease patients, the integration between post-acute care and long-term care systems must be strengthened. The Committee recommends a "case management" model where physician-led teams work with dedicated care managers to ensure rehabilitation adherence and risk-factor control, preventing the recurrence of acute events.
Strengthening the Immunization Shield
Vaccination is widely regarded as the most cost-effective public health intervention for extending healthy life expectancy. Yet, in Taiwan, adult vaccination rates remain suboptimal. Influenza vaccination coverage among those 65 and older hovers around 50%, while pneumococcal vaccination completion is below 40%.
To support the "Healthy Taiwan" objectives, the Committee suggests embedding vaccination into routine chronic disease management. For instance, the "Family Physician Program" could include pneumococcal and Covid-19 vaccinations as key performance indicators. Additionally, the Taiwan Centers for Disease Control (CDC) is encouraged to adopt more efficient regulatory processes. By moving toward a risk-based, tiered testing approach for vaccine lot release—rather than the current batch-by-batch system—Taiwan can ensure faster access to new vaccines while maintaining rigorous safety standards.
Digital Innovation: The Health Coin and Contactless Care
The digital transformation of healthcare is no longer an option but a necessity. Taiwan’s "My Health Bank" and the "Health Coin" initiative provide a foundation for this shift. The Health Coin program currently offers digital incentives for preventive activities like screenings. The Committee recommends scaling this ecosystem to include "high-frequency" behaviors, such as daily physical activity and weight management, verified through wearable devices.
Moreover, the expansion of "contactless care" through telehealth is essential for reaching underserved and remote populations. By integrating teleconsultation, electronic prescriptions, and pharmaceutical logistics into a seamless model, Taiwan can ensure that the elderly and those with limited mobility receive continuous care without the need for frequent, taxing visits to large medical centers.
Establishing a Comprehensive Cancer Control Framework
For over 40 years, cancer has been the leading cause of death in Taiwan. Despite increased investment, screening participation remains uneven. While cervical cancer screening has surpassed a 50% participation rate, breast and colorectal cancer screenings remain below 40%. Many cancers, such as prostate and ovarian cancer, are frequently detected only at advanced stages, leading to higher mortality rates.
The Committee’s recommendation is twofold: increase screening coverage through targeted, risk-based strategies and improve access to innovative treatments. This includes optimizing reimbursement for Next-Generation Sequencing (NGS) to allow for precision diagnostics.
A pivotal part of this strategy is the institutionalization of the Cancer Drugs Fund. The Committee urges the government to expand the fund to a NT$10 billion level to ensure that patients have access to breakthrough therapies that might otherwise be delayed by NHI budget constraints. Establishing a clear legal framework and predictable funding sources for this fund is seen as vital for its long-term success.
Analysis: The Path Forward for NHI Sustainability
The proposed reforms represent a fundamental shift in how Taiwan views its citizens’ health. By moving from a "reactive" system to a "proactive" one, the government aims to decouple the aging of the population from the exponential growth of healthcare costs.
The economic implications are significant. If Taiwan can successfully reduce the "unhealthy" years of its citizens from 10% of their lifespan to 8%, the savings in long-term care and acute medical interventions would be monumental. However, the transition requires overcoming several hurdles: the fragmentation of data across different health platforms, the need for legislative changes to support new funding models, and the cultural shift required for the public to prioritize preventive wellness over late-stage treatment.
As the Lai Ching-te administration moves forward, the success of the "Healthy Taiwan" vision will depend on the government’s ability to foster cross-sector coordination. Public-private partnerships will be the engine of innovation, particularly in the realms of smart healthcare and precision medicine. If implemented effectively, these strategies could serve as a global blueprint for other nations facing similar demographic "graying" challenges, ensuring that a super-aged society can still be a vibrant, healthy, and economically viable one.
Asep Darmawan
